 |
March 05, 2010 |
|
What about the effects of HRT on quality of life?
|
Barbara Howard V., PhD, Medstar Research Institute, Washington, DC, USA
|
Expert Opinions
Video 1:20 min.
7 MB
|
 |
February 26, 2010 |
|
What is the importance of hemorrhage in the natural progression of plaques?
|
Renu Virmani, MD CVPath Institute, Gaithersburg, MD, USA
|
Expert Opinions
Video 0:37 min.
3 MB
|
 |
February 19, 2010 |
|
What is the importance of adipocyte size? |
André Tchernof, PhD Molecular Endocrinology and Oncology Research Centre, Laval University Medical Research Centre, Québec, QC, Canada
|
Expert Opinions
Video 1:29 min.
7 MB
|
 |
February 15, 2010 |
|
Clinical impact of obesity in the REACH registry |
The International Chair on Cardiometabolic Risk
|
Webcasts
Video 5:31 min.
27 MB
|
 |
February 12, 2010 |
|
What are the current indications for HRT? |
Barbara Howard V., PhD, Medstar Research Institute, Washington, DC, USA
|
Expert Opinions
Video 1:05 min.
5 MB
|
 |
February 05, 2010 |
|
From the ONTARGET study results, does the method used to reduce blood pressure matter in terms of its impact on cardiovascular events? |
Luis Miguel Ruilope, MD, Professor, Internal Medicine, Complutense University, Head of the Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain
|
Expert Opinions
Video 1:19 min.
7 MB
|
 |
January 29, 2010 |
|
Why could apolipoprotein B be better than cholesterol in estimating cardiovascular disease risk? |
Chris Packard, DSc, FRSE , Research Director, North Glasgow University Hospital, Professor of Vascular Biochemistry, University of Glasgow, Glasgow, UK
|
Expert Opinions
Video 0:49 min.
4 MB
|
 |
January 22, 2010 |
|
Is the debate over regarding the harmful cardiovascular effects of HRT in post-menopausal women? |
Barbara V. Howard, PhD, Medstar Research Institute, Washington, DC, USA
|
Expert Opinions
Video 1:09 min.
6 MB
|
 |
January 15, 2010 |
|
Physical activity: it’s never too late |
The International Chair on Cardiometabolic Risk
|
Webcasts
Video 5:37 min.
28 MB
|
 |
January 15, 2010 |
|
What are the effects of CB1 activation on adipocytes? |
Vincenzo Di Marzo, PhD, Istituto di Chimica Biomolecolare Pozzuoli (NA), Italy
|
Expert Opinions
Video 0:49 min.
4 MB
|
 |
January 08, 2010 |
|
Are better drugs available to raise HDL cholesterol? |
H. Bryan Brewer, Jr., MD, Director, Lipoprotein and Atherosclerosis Research, MedStar Research Institute, Cardiovascular Research Institute, Washington, DC, USA
|
Expert Opinions
Video 1:23 min.
5 MB
|
 |
January 05, 2010 |
|
In which patients should we measure apolipoprotein B? |
Christie Ballantyne, MD, FACC, FACP, Director, Center for Cardiovascular Disease Prevention, Chief Section of Atherosclerosis and Vascular Medicine, Methodist DeBakey Heart Center and Baylor College of Medicine, Houston, TX, USA
|
Expert Opinions
Video 0:47 min.
3 MB
|
 |
December 18, 2009 |
|
Could there be a link between HDL and diabetes? |
Arnold von Eckardstein, MD Institute of Clinical Chemistry, University Hospital of Zurich and Center for Integrative Human Biology, University of Zurich, Zurich, Switzerland
|
Expert Opinions
Video 1:23 min.
5 MB
|
 |
December 15, 2009 |
|
Visceral/ectopic fat: present and future contributions of imaging techniques |
The International Chair on Cardiometabolic Risk
|
Webcasts
Video 5:24 min.
26 MB
|
 |
December 11, 2009 |
|
Why do we need to improve the current atherosclerosis classification? |
Renu Virmani, MD CVPath Institute, Gaithersburg, MD, USA
|
Expert Opinions
Video 1:01 min.
5 MB
|